Alcon’s PATANASE® Nasal Spray Approved by FDA for Treatment of Nasal Allergy Symptoms

LogoLogo

Back to: News Release

Download Formats

Share This Logo

URL:

Smart Multimedia Gallery

U.S. Food and Drug Administration has approved PATANASE nasal spray for the relief of the symptoms of seasonal allergic rhinitis in patients 12 years of age and older. (Photo: Business Wire)
U.S. Food and Drug Administration has approved PATANASE nasal spray for the relief of the symptoms of seasonal allergic rhinitis in patients 12 years of age and older. (Photo: Business Wire)Photo

U.S. Food and Drug Administration has approved PATANASE nasal spray for the relief of the symptoms of seasonal allergic rhinitis in patients 12 years of age and older. (Photo: Business Wire)

Download Formats

More
http://www.businesswire.com/multimedia/google/20080415006615/en/1606695
http://www.businesswire.com/multimedia/google/20080415006615/en/1606695Logo

Better Be Business Wired.

Business Wire is the leading source for press releases, photos, multimedia and regulatory filings from companies and groups throughout the world.